4SC AG: 4SC – Resminostat and RESMAIN Study Update
4SC AG (4SC, FSE Prime Standard: VSC) today announced that the Data Safety Monitoring Board (DSMB), an independent committee of clinical and drug safety experts, recommends again continuation of the ongoing pivotal RESMAIN study without modification. The pivotal RESMAIN study, Mehr




